EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases

Yuan Zeng iD, Yifan Wu, Qian Zhang iD, Xinhua Xiao iD

mBio · 16.01.2024 · 15 (1)

DOI: 10.1128/mbio.02032-23 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift mBio, erschienen am 16.01.2024. Verfasst von Yuan Zeng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Gastrointestinal Microbiome, Glucagon-Like Peptide 1. Die Arbeit wurde bisher 157-mal zitiert (Crossref) und nennt 165 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: MOST | National Natural Science Foundation of China (NSFC), Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation), Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gut microbiota exert influence on gastrointestinal mucosal permeability, bile acid metabolism, short-chain fatty acid synthesis, dietary fiber fermentation, and farnesoid X receptor/Takeda G protein-coupled receptor 5 (TGR5) signal transduction. The incretin glucagon-like peptide 1 (GLP-1) is mainly produced by L cells in the gut and regulates postprandial blood glucose. Changes in gut microbiota composition and function have been observed in obesity and type 2 diabetes (T2D). Meanwhile, the function and rhythm of GLP-1 have also been affected in subjects with obesity or T2D. Therefore, it is necessary to discuss the link between the gut microbiome and GLP-1. In this review, we describe the interaction between GLP-1 and the gut microbiota in metabolic diseases. On the one hand, gut microbiota metabolites stimulate GLP-1 secretion, and gut microbiota affect GLP-1 function and rhythm. On the other hand, the mechanism of action of GLP-1 on gut microbiota involves the inflammatory response. Additionally, we discuss the effects and mechanism of various interventions, such as prebiotics, probiotics, antidiabetic drugs, and bariatric surgery, on the crosstalk between gut microbiota and GLP-1. Finally, we stress that gut microbiota can be used as a target for metabolic diseases, and the clinical application of GLP-1 receptor agonists should be individualized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Gastrointestinal MicrobiomeGlucagon-Like Peptide 1HumansObesitySignal Transduction

Stichwörter der Autor:innen

glucagon-like peptide 1gut microbiotaprebioticsprobioticstype 2 diabetes

Substanzen

Glucagon-Like Peptide 1

Autor:innen und Institutionen

  • Department of Endocrinology, Key Laboratory of Endocrinology, Ministry of Health, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Sciences, Beijing, China.

ORCID-Profile: Yuan Zeng, Qian Zhang, Xinhua Xiao

Förderung

  • MOST | National Natural Science Foundation of China (NSFC)
  • Natural Science Foundation of Beijing Municipality (Beijing Natural Science Foundation)
  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
  • MOST | National Key Research and Development Program of China (NKPs)
  • Beijing Municipal Human Resources and Social Security Bureau (BMHRSSB)
  • Chinese Academy of Medical Sciences (CAMS)
  • National High Level Hospital Clinical Research Funding

Zitieren

APA

Zeng, Y., Wu, Y., Zhang, Q., & Xiao, X. (2024). Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases. mBio, 15(1). https://doi.org/10.1128/mbio.02032-23

Vancouver

Zeng Y, Wu Y, Zhang Q, Xiao X. Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases. mBio. 2024;15(1). doi:10.1128/mbio.02032-23

BibTeX
@article{Zeng2024,
  author = {Zeng, Yuan and Wu, Yifan and Zhang, Qian and Xiao, Xinhua},
  title = {Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases},
  journal = {mBio},
  year = {2024},
  volume = {15},
  number = {1},
  doi = {10.1128/mbio.02032-23}
}
Kostenlos starten →